Connect Biopharma Holdings Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 05/15/2026 | 5.39 M | $13.12 M | 12.53% | 9.68% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 1.23 M | $3.23 M | 0.00% | 2.22% |
| 683 CAPITAL MANAGEMENT, LLC | 05/15/2026 | 900.00 K | $2.36 M | 100.00% | 1.62% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 792.70 K | $2.08 M | 0.00% | 1.42% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 742.40 K | $1.95 M | 100.00% | 1.33% |
| RICHMOND BROTHERS, INC. | 05/11/2026 | 476.58 K | $1.25 M | 174.71% | 0.86% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 474.60 K | $1.24 M | 908.72% | 0.85% |
| BML CAPITAL MANAGEMENT, LLC | 05/06/2026 | 408.89 K | $1.07 M | 0.00% | 0.73% |
| KNOTT DAVID M JR | 05/14/2026 | 387.84 K | $1.02 M | 93.92% | 0.70% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 310.00 K | $812.20 K | 100.00% | 0.56% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 278.81 K | $730.48 K | 289.92% | 0.50% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 209.49 K | $553.91 K | 100.00% | 0.38% |
| DIADEMA PARTNERS LP | 05/15/2026 | 200.69 K | $525.81 K | 100.00% | 0.36% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 05/15/2026 | 150.00 K | $360.30 K | 100.00% | 0.27% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 144.60 K | $378.85 K | 0.00% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 120.70 K | $316.23 K | -15.65% | 0.22% |
| CITADEL ADVISORS LLC | 05/15/2026 | 76.07 K | $199.31 K | -23.54% | 0.14% |
| MARSHALL WACE, LLP | 05/15/2026 | 66.01 K | $172.95 K | -48.58% | 0.12% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 51.48 K | $134.86 K | 100.00% | 0.09% |
| PERSISTENT ASSET PARTNERS LTD | 05/12/2026 | 50.75 K | $132.96 K | 89.54% | 0.09% |
| KOA WEALTH MANAGEMENT, LLC | 04/29/2026 | 49.60 K | $129.95 K | 0.00% | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 47.47 K | $124.36 K | 100.00% | 0.09% |
| FIFTH LANE CAPITAL, LP | 05/15/2026 | 45.00 K | $117.90 K | 100.00% | 0.08% |
| XTX TOPCO LTD | 05/15/2026 | 41.13 K | $107.76 K | 100.00% | 0.07% |
| ROYAL BANK OF CANADA | 05/15/2026 | 40.40 K | $106.00 K | 0.00% | 0.07% |
| JANE STREET GROUP, LLC | 05/12/2026 | 39.60 K | $103.75 K | -51.84% | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 37.00 K | $96.94 K | 0.00% | 0.07% |
| CITADEL ADVISORS LLC | 05/15/2026 | 36.60 K | $95.89 K | 100.00% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 32.13 K | $84.18 K | 37.77% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 30.40 K | $79.65 K | 100.00% | 0.05% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 29.83 K | $78.16 K | 100.00% | 0.05% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 19.77 K | $51.79 K | 19.77% | 0.04% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 16.91 K | $44.00 K | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 15.67 K | $41.06 K | 100.00% | 0.03% |
| HRT FINANCIAL LP | 05/14/2026 | 15.30 K | $40.00 K | -8.85% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 14.90 K | $39.04 K | 100.00% | 0.03% |
| 04/21/2026 | 12.90 K | $33.79 K | 0.00% | 0.02% | |
| JANE STREET GROUP, LLC | 05/12/2026 | 12.40 K | $32.49 K | 100.00% | 0.02% |
| MONOGRAPH WEALTH ADVISORS, LLC | 05/13/2026 | 11.13 K | $29.16 K | 0.00% | 0.02% |
| FNY INVESTMENT ADVISERS, LLC | 04/15/2026 | 5.00 K | $13.00 K | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 3.59 K | $9.41 K | 62.52% | 0.01% |
| RHUMBLINE ADVISERS | 05/12/2026 | 780 | $2.04 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 121 | $351 | 0.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 33 | $86 | -98.96% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 6 | $16 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $3 | 100.00% | 0.00% |
| OMERS ADMINISTRATION CORP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
Connect Biopharma Holdings Ltd institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Connect Biopharma Holdings Ltd. The most heavily invested institutionals were:
Ikarian Capital, LLC: 5.39 M
BOOTHBAY FUND MANAGEMENT, LLC: 1.23 M
683 Capital Management, LLC: 900,000
PERCEPTIVE ADVISORS LLC: 792,696
ADAR1 Capital Management, LLC: 742,400
Richmond Brothers, Inc.: 476,584
22.90% of Connect Biopharma Holdings Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 12.92 M shares in the last 24 months. This purchase volume represents approximately $34.23 M in transactions.